382 related articles for article (PubMed ID: 10780311)
1. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
[TBL] [Abstract][Full Text] [Related]
2. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
4. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
[TBL] [Abstract][Full Text] [Related]
6. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey.
Lowe GD; Upton MN; Rumley A; McConnachie A; O'Reilly DS; Watt GC
Thromb Haemost; 2001 Aug; 86(2):550-6. PubMed ID: 11522002
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.
Høibraaten E; Abdelnoor M; Sandset PM
Thromb Haemost; 1999 Oct; 82(4):1218-21. PubMed ID: 10544901
[TBL] [Abstract][Full Text] [Related]
10. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
Waselenko JK; Nace MC; Alving B
Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study.
Sidelmann JJ; Jespersen J; Andersen LF; Skouby SO;
BJOG; 2003 Jun; 110(6):541-7. PubMed ID: 12798469
[TBL] [Abstract][Full Text] [Related]
13. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
14. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
[TBL] [Abstract][Full Text] [Related]
15. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
16. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.
Ott J; Kaufmann U; Bentz EK; Huber JC; Tempfer CB
Fertil Steril; 2010 Mar; 93(4):1267-72. PubMed ID: 19200981
[TBL] [Abstract][Full Text] [Related]
17. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy.
Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B
Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213
[TBL] [Abstract][Full Text] [Related]
20. Sex and gender issues and venous thromboembolism.
Moores L; Bilello KL; Murin S
Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
